Michael H. Tardugno
Net Worth

Last updated:

What is Michael H. Tardugno net worth?

The estimated net worth of Mr. Michael H. Tardugno is at least $18,032,365 as of 12 Apr 2022. He owns shares worth $32,365 as insider and has received compensation worth at least $18,000,000 in Imunon, Inc..

What is the salary of Michael H. Tardugno?

Mr. Michael H. Tardugno salary is $1,000,000 per year as Executive Chairman, Pres & Chief Executive Officer in Imunon, Inc..

How old is Michael H. Tardugno?

Mr. Michael H. Tardugno is 74 years old, born in 1951.

What stocks does Michael H. Tardugno currently own?

As insider, Mr. Michael H. Tardugno owns shares in one company:

Company Title Shares Price per share Total value
Imunon, Inc. (CLSN) Executive Chairman, Pres & Chief Executive Officer 16,513 $1.96 $32,365

What does Imunon, Inc. do?

Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.

CLSN logo
CLSN
Imunon, Inc.
$1.96

Michael H. Tardugno insider trading

Imunon, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Celsion Corporation Common Stock 4,000 $3.53 $14,128
Purchase
Celssion Corporation Common Stock 5,000 $2.16 $10,810
Purchase
Celsion Corporation Common Stock 7,500 $2.07 $15,488
Purchase
Celsion Corporation Common Stock 2,500 $2.3 $5,750
Purchase
Celsion Corporation Common Stock 7,500 $2.38 $17,843
Purchase
Celsion Corporation Common Stock 10,000 $1.14 $11,400
Purchase
Celsion Corporation Common Stock 5,000 $1.25 $6,245
Purchase
Celsion Corporation Common Stock 7,500 $1.35 $10,125
Purchase
Celsion Corporation Common Stock 3,000 $1.27 $3,807
Purchase
Celsion Corporation Common Stock 2,000 $1.27 $2,536
Purchase
Celsion Corporation Common Stock 4,500 $1.2 $5,396
Purchase
Celsion Corporation Common Stock 6,500 $1.13 $7,313
Purchase
Celsion Corporation Common Stock 5,000 $2.29 $11,425
Purchase
Celsion Corporation Common Stock 8,000 $3.12 $24,952
Purchase
Celsion Corporation Common Stock 5,000 $3.2 $15,990
Purchase
Celsion Corporation Common Stock 4,000 $3.84 $15,360
Purchase
Celsion Corporation Common Stock 2,800 $3.59 $10,052
Purchase
Celsion Corporation Common Stock 5,000 $1.08 $5,400
Purchase
Celsion Corporation Common Stock 10,000 $1.35 $13,460
Option
Celsion Corporation Common Stock 17,271 $2.77 $47,841
Purchase
Celsion Corporation Common Stock 5,000 $5.04 $25,175
Purchase
Celsion Corporation Common Stock 5,000 $2.19 $10,950
Purchase
Warrants to purchase Common Stock 17,271 $2.77 $47,841
Purchase
Celsion Corporation Common Stock 17,271 $2.77 $47,841
Purchase
Warrants to Purchase Common Stock 17,083 N/A N/A
Purchase
Series A Redeemable Convertible Preferred Stock 41 $2.4 $98
Purchase
Celsion Common Stock 4,000 $3.95 $15,800
Option
Common Stock Restricted 16,667 N/A N/A
Option
Common Stock 16,667 N/A N/A
Purchase
Common Stock 6,000 $3.21 $19,260
Purchase
Common Stock 5,000 $3.3 $16,500
Purchase
Common Stock 3,750 $2.56 $9,600
Purchase
Common Stock 3,000 $2.83 $8,502
Purchase
Common Stock 2,500 $4.39 $10,975
Purchase
Common Stock Options 18,750 $5.5 $103,125
Option
Common Stock Restricted 33,333 N/A N/A
Option
Common Stock 33,333 N/A N/A
Purchase
Common Stock 2,384 $4.82 $11,479
Purchase
Common Stock 7,616 $3.46 $26,351

Imunon key executives

Imunon, Inc. executives and other stock owners filed with the SEC:

  • Dr. Khursheed Anwer M.B.A., Ph.D. (65) Executive Vice President & Chief Scientific Officer
  • Dr. Nicholas Borys (66) Executive Vice President & Chief Medical Officer
  • Mr. Jeffrey W. Church CPA, CPA (68) Chief Financial Officer, Executive Vice President & Corporation Sec.
  • Mr. Michael H. Tardugno (74) Executive Chairman, Pres & Chief Executive Officer